在过敏研究中不朽化乳腺细胞系的当前使用趋势:系统性审查
Ashley Jia Wen Yip1, Yu Zhao Lee2, Audrey Siew Foong Kow3
1School of Science, Monash University Malaysia, Jalan Lagoon SelatanSubang Jaya, 47500, Bandar Sunway, Selangor, Malaysia.
Immunologic research
|January 21, 2025
概括
本系统性审查审查了在过敏研究中使用的巨细胞系 (HMC-1,LAD2,RBL-2H3). 它旨在标准化体外巨细胞模型,以更好地理解和开发有效的过敏疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 过敏性疾病是多因素的,受遗传学,环境和社会经济因素的影响.
- 乳腺细胞是启动过敏反应的关键参与者.
- 实验室乳腺腺细胞系对于研究过敏病原性至关重要,但研究协议缺乏标准化.
研究的目的:
- 系统地审查在过敏研究中使用三个主要的实验室永生性巨细胞系 (HMC-1,LAD2,RBL-2H3).
- 识别培养介质,诱导剂和调解剂分析中的不一致性.
- 为提供一个指南,用于标准化瘤细胞模型在过敏研究.
主要方法:
- 科学文章的系统审查.
- 对细胞源,培养条件,脱粒诱导剂和释放媒介的分析.
- 专注于HMC-1,LAD2和RBL-2H3巨细胞系.
主要成果:
- 在培养介质成分和用于巨细胞脱粒的诱导剂类型中存在变化.
- 不同的乳腺细胞系和实验条件产生不同的结果.
- 缺乏标准化的协议阻碍了比较分析和可复制性.
结论:
- 为了可靠的过敏研究,对体外巨细胞系 (HMC-1,LAD2,RBL-2H3) 的标准化至关重要.
- 一种标准化的方法将改善对过敏机制的理解.
- 这一审查为开发未来有效的过敏疗法提供了基础.
相关概念视频
02:06Allergic Reactions
26.4K
Overview
26.4K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K